Posts
April 03 2017
Atossa Genetics Inc. announced the closing of their Underwritten offering in the amount of $4,397,500. EG&S acted as counsel to the Underwriter.
April 03 2017
Dynatronics Corporation announced the closing of their PIPE in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
March 31 2017
Douglas S. Ellenoff, a member of the Firm, wrote an article for LexisNexis; Lexis Practice Advisor titled “Market Trends: Crowdfunding.”
Click here to read the article
March 31 2017
Biocept Inc. announced the closing of their Registered Direct offering in the amount of $9,296,672. EG&S acted as counsel to the lead Investor.
March 30 2017
Kayne Anderson Acquisition Corp. announced the closing of its initial public offering in the amount of $350,000,000. EG&S acted as counsel to Kayne Anderson.
March 24 2017
Delaware Court of Chancery granting summary judgment to EG&S client, Shu Kaneko, freeing him from liability on all the claims brought against him by the receiver for Southern China Livestock International, Inc. (SCLI). The Receiver brought claims against Mr. Kaneko seeking approximately $8M in damages, despite SCLI having given Mr. Kaneko a full release as part of a settlement agreement in February 2013, sixteen months before the Receiver first filed suit. EG&S acted as counel to Mr. Kaneko. J.B. Horgan, an Associate of the Firm, was on this case from the beginning, having written the summary judgment brief and argued it before the Chancery Court.
March 22 2017
Northwest Biotherapeutics Inc. announced the closing of their Registered Direct offering in the amount of $7,399,359. EG&S acted as counsel to the Placement Agent.
March 21 2017
Rennova Health, Inc. announced the closing of their PIPE offering in the amount of $8,750,000. EG&S acted as counsel to the Investor.